Zoetis Trading at Its Lowest P/E Ratio Ever
Zoetis (NYSE: ZTS), a leading animal healthcare company, is currently trading at its lowest price-to-earnings (P/E) ratio ever, at 19 times earnings. This marks a significant decline from its historical average of nearly 39 over the past decade. The drop is attributed to short-term issues, including backlash over the side effects of its drug Librela, which led to a 16% decline in sales in 2025.
Topics: animal health market reaction P/E ratio product issues stock valuation Zoetis